Surgery Websites
Surgical Innovations »  People »  Participating Faculty »  Shant Vartanian, M.D.
Shant Vartanian, M.D.

Shant Vartanian, M.D.

Assistant Professor of Surgery
Division of Vascular & Endovascular Surgery
Interim Chief
Department of Surgery at Zuckerberg San Francisco General

Contact Information

Division of Vascular and Endovascular Surgery, UCSF
400 Parnassus Avenue, A-501
San Francisco, CA 94143-0957
Phone: (415) 353-2357
Fax: (415) 353-2669
Shant.Vartanian@ucsf.edu
Open Popup
  • 1994-98, Stanford University, B.Sc. (HON) Biological Sciences
  • 1999-03, Saint Louis University, Doctor of Medicine
  • 2003-04, University of California, San Francisco, Intern, General Surgery
  • 2004-09, University of California, San Francisco, Resident, General Surgery
  • 2005-07, University of California, San Francisco, Post-Doctoral Research Fellow, Laboratory for Accelerated Vascular Research
  • 2009-10, University of California, San Francisco, Chief Resident, General Surgery
  • 2010-2012, University of California, San Francisco, Fellow, Vascular Surgery
  • American Board of Surgery, 2011
  • Abdominal Aortic Aneurysm
  • Aortic Dissection
  • Carotid Artery Disease
  • Complex Limb Revascularization
  • Critical Limb Ischemia
  • Diabetic Vascular Disease
  • Dialysis Access
  • Endovascular Aneurysm Repair
  • Mesenteric Artery Disease
  • Peripheral Artery Disease
  • Thoracic Aortic Aneurysm
  • Thoracic Outlet Syndrome
  • Comparative effectiveness of endovacular interventions for lower extremity arterial disease
  • Endovascular interventions for acute and chronic aortic conditions

Shant Vartanian, M.D. is an assistant professor in the Division of Vascular and Endovascular Surgery. He has been with UCSF since 2003, completing his residency in General Surgery and a fellowship in Vascular Surgery.

He has played a leading role in the revitalization of the Vascular Surgery program at ZSFG. The rapidly maturing program routinely handles aortic trauma, complex endovascular interventions and is a busy clinical practice offering care for peripheral vascular and venous disorders for San Francisco Health Network (SFHN) patients. Dr. Vartanian started and is the medical director of the Vascular Lab, which performs over 1200 non-invasive diagnostic studies for the ZSFG community annually. His clinical research is focused on comparative effectiveness, quality improvement for dialysis access and innovations in dialysis access delivery.

Dr. Vartanian is interested in comparing the effectiveness of endovascular treatments for peripheral arterial disease. By understanding the safety, effectiveness, and cost of each intervention, the aim of the research is to assist patients and clinicians in making informed decisions about treatment options.

Nicole Rich, M.D. 7/2015 - 6/2017
  1. Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease. Johnston PC, Vartanian SM, Runge SJ, Hiramoto JS, Eichler CM, Owens CD, Schneider DB, Conte MS. J Vasc Surg. 2012 May 24. [Epub ahead of print]
  2. Endothelial Notch4 signaling induces hallmarks of brain arteriovenous malformations in mice. Murphy PA, Lam MT, Wu X, Kim TN, Vartanian SM, Bollen AW, Carlson TR, Wang RA. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):10901-6. Epub 2008 Jul 30.
  3. Therapeutic angiogenesis. Vartanian SM, Sarkar R. Vasc Endovascular Surg. 2007 Jun-Jul;41(3):173-85.
  4. Oklahoma prosthesis: resection of tumor of clavicle and chest wall reconstructed with a custom composite graft. Vartanian SM, Colaco S, Orloff LE, Theodore PR. Ann Thorac Surg. 2006 Jul;82(1):332-4.
  5. Ischemic colitis: spectrum of disease and outcome. Scharff JR, Longo WE, Vartanian SM, Jacobs DL, Bahadursingh AN, Kaminski DL. Surgery. 2003 Oct;134(4):624-9; discussion 629-30.

Site Directory
    X